Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective.

Area of Science:

• Endocrinology and Metabolism
• Immunology
• Public Health

Background:

• Current type 1 diabetes screening primarily targets relatives, missing ~90% of cases in individuals without a family history.
• Advances in disease-modifying therapies necessitate broader strategies for early identification of at-risk individuals.
• Existing genetic and autoantibody screening methods provide valuable insights into disease progression and timing.

Purpose of the Study:

• To review ongoing efforts and discuss the feasibility of general population screening for type 1 diabetes.
• To explore the need for population-wide screening in light of new therapeutic developments.
• To establish standardized guidelines for monitoring and follow-up of individuals identified through screening.

Main Methods:

• Discussion and review of ongoing population screening initiatives for type 1 diabetes.
• Analysis of data from genetic and autoantibody screening programs.
• Consideration of challenges and recommendations for implementing population screening.

Main Results:

• Significant progress has been made in understanding disease progression and screening timing through existing programs.
• The feasibility and need for population screening are being actively considered.
• Hurdles for successful implementation have been identified, and initial recommendations are proposed.

Conclusions:

• Population screening for type 1 diabetes is a critical consideration given recent therapeutic advancements.
• Addressing implementation hurdles is essential for establishing standardized monitoring and follow-up protocols.
• This initiative aims to improve early detection and management of type 1 diabetes across the general population.